| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |